Searching News Database: DNA vaccines
HSMN NewsFeed - 8 May 2017
Regeneron and Inovio Enter Immuno-Oncology Clinical Study Agreement for Glioblastoma Combination Therapy
Regeneron and Inovio Enter Immuno-Oncology Clinical Study Agreement for Glioblastoma Combination Therapy
HSMN NewsFeed - 12 Oct 2016
Inovio Expands Executive Team to Advance its DNA Immunotherapy Product Portfolio
Inovio Expands Executive Team to Advance its DNA Immunotherapy Product Portfolio
HSMN NewsFeed - 4 Aug 2016
Inovio Pharmaceuticals Appoints Dr. Ami Shah Brown As Vice President Regulatory Affairs
Inovio Pharmaceuticals Appoints Dr. Ami Shah Brown As Vice President Regulatory Affairs
HSMN NewsFeed - 17 Dec 2014
Inovio Pharmaceuticals Appoints Zane Yang, M.D. Vice President, Clinical Development, Oncology
Inovio Pharmaceuticals Appoints Zane Yang, M.D. Vice President, Clinical Development, Oncology
HSMN NewsFeed - 1 Apr 2014
Inovio Pharmaceuticals Continues Building Its Senior Team With the Appointment of VP of Quality
Inovio Pharmaceuticals Continues Building Its Senior Team With the Appointment of VP of Quality
HSMN NewsFeed - 2 Nov 2012
Vical Names Mammen P. Mammen, Jr., M.D., Vice President, Clinical Vaccines
Vical Names Mammen P. Mammen, Jr., M.D., Vice President, Clinical Vaccines
HSMN NewsFeed - 6 Sep 2011
Inovio Pharmaceuticals Adds Two Medical Innovators to Its Scientific Advisory Board
Inovio Pharmaceuticals Adds Two Medical Innovators to Its Scientific Advisory Board
HSMN NewsFeed - 13 Apr 2011
Raptor Pharmaceutical Adds Three Biopharmaceutical Leaders to Its Board of Directors
Raptor Pharmaceutical Adds Three Biopharmaceutical Leaders to Its Board of Directors
HSMN NewsFeed - 20 Sep 2007
Vical Licensee Sanofi-aventis Initiates Phase 3 Trial to Reduce Amputations
Vical Licensee Sanofi-aventis Initiates Phase 3 Trial to Reduce Amputations
HSMN NewsFeed - 21 Aug 2007
Inovio Biomedical Appoints Dr. Michael Fons as Vice President, Corporate Development
Inovio Biomedical Appoints Dr. Michael Fons as Vice President, Corporate Development
HSMN NewsFeed - 5 Jun 2007
Inovio Biomedical Stops Enrollment of Phase III Clinical Trials for Head & Neck Cancer
Inovio Biomedical Stops Enrollment of Phase III Clinical Trials for Head & Neck Cancer
HSMN NewsFeed - 24 Jan 2007
Vical Highlights Transition to Phase 3 Trial With Allovectin-7(R) for Metastatic Melanoma
Vical Highlights Transition to Phase 3 Trial With Allovectin-7(R) for Metastatic Melanoma
HSMN NewsFeed - 4 Jan 2007
Vical Initiates Pivotal Phase 3 Trial of Allovectin-7(R) as First-line Therapy for Metastatic Melanoma
Vical Initiates Pivotal Phase 3 Trial of Allovectin-7(R) as First-line Therapy for Metastatic Melanoma
HSMN NewsFeed - 15 Nov 2006
Bayhill Therapeutics Names Robert S. King Vice President of Manufacturing
Bayhill Therapeutics Names Robert S. King Vice President of Manufacturing
HSMN NewsFeed - 14 Nov 2006
Inovio Biomedical Grants VGX Pharmaceuticals License to Develop Novel Cancer Therapeutic
Inovio Biomedical Grants VGX Pharmaceuticals License to Develop Novel Cancer Therapeutic
HSMN NewsFeed - 7 Nov 2006
Inovio Biomedical Grants Wyeth Pharmaceuticals License to Develop Infectious Disease DNA Vaccines
Inovio Biomedical Grants Wyeth Pharmaceuticals License to Develop Infectious Disease DNA Vaccines
HSMN NewsFeed - 17 Oct 2006
Inovio Biomedical Acquires Rights to DNA Vaccine Licenses and Intellectual Property from Valentis
Inovio Biomedical Acquires Rights to DNA Vaccine Licenses and Intellectual Property from Valentis
HSMN NewsFeed - 2 Oct 2006
PowderMed to Conduct U.S. Clinical Trial of DNA-Based Annual Influenza Vaccine
PowderMed to Conduct U.S. Clinical Trial of DNA-Based Annual Influenza Vaccine
Additional items found! 31
Members Archive contains
31 additional stories matching:
DNA vaccines
(Password required)
DNA vaccines
(Password required)
FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.
RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!